Letter to the Editor: Popsicle Politics
By Marcy Darnovsky,
Mother Jones
| 08. 31. 2006
Both "Breeder Reaction" and "Souls on Ice" begin to tackle the profound issues and difficult questions raised by new human biotechnologies: How do we take reproductive and genetic technologies out of the free-market realm of anything-goes-for-those-who-can-pay, while making sure that we protect reproductive rights? How do we reap the potential benefits of human biotech, while making sure that we're not on the road either to a brave new world of designer babies or to ever greater health inequities because of hugely expensive designer medicine?
A number of countries, including Canada and the United Kingdom, have put in place comprehensive policies to regulate assisted reproduction and research that involves human embryos. But not the United States—here again, we're a Wild West, with scant public oversight.
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...